Who Benefits Most
Why Peptide Therapy Is Growing in Connecticut Connecticuts growing interest in longevity and regenerative medicine has driven patients toward therapies that merge science with natural healing
This intra-company comparison is particularly interesting because it reveals Novo Nordisk's multi-pronged strategy for next-generation obesity therapy
My Doctor Had Never Heard of It
Protocol : BPC-157: 500 mcg/day (near injury or systemic) CJC-1295 w/ DAC: 2 mg twice per week Ipamorelin: 100200 mcg, 12x/day Duration: 68 weeks max Stacking Summary Potential Side Effects and Safety Profile of BPC-157 Compared to most performance-enhancing drugs, peptides, or even over-the-counter recovery aids, BPC-157 is remarkably well-tolerated
(1) Huang T, Zhang K, Sun L, Xue X, Zhang C, Shu Z, Mu N, Gu J, Zhang W, Wang Y, Zhang Y, Zhang W